Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Larimar Therapeutics, Inc. (ZFGN)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
   8-K10-K10-K10-K10-K10-K10-K10-K
Revenues  24.30.00.00.00.00.00.00.0
Cost of goods sold  36.50.00.00.00.00.00.00.0
Gross profit  -12.30.00.00.00.00.00.00.0
            Gross margin  -50.6%       
Selling, general and administrative   [+]12.350.542.82.413.212.218.319.2
Research and development     20.847.940.839.954.6
Other operating expenses  12.00.3-0.6     
EBITDA   [+]   -23.1-60.9-52.8-58.0-73.7
            EBITDA margin  -150.6%       
Depreciation and amortization     0.10.30.20.20.1
EBIT   [+]-36.5-50.8-42.2-23.2-61.1-53.0-58.2-73.8
            EBIT margin  -150.6%       
Interest income, net   [+]    0.00.80.4-0.4
Other income (expense), net   [+]1.20.2-0.30.0-0.20.10.0-0.1
Pre-tax income  -35.4-50.6-42.5-23.2-61.4-52.0-57.9-74.3
Income taxes  0.00.00.00.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income  -35.4-50.6-42.5-23.1-61.4-52.0-57.9-74.3
            Net margin  -145.8%       
   
Basic EPS   [+]($1.37)($2.95)($3.57)($3.80)($1.90)($1.90)($2.12)($2.78)
Diluted EPS   [+]($1.37)($2.95)($3.57)($3.80)($1.90)($1.90)($2.12)($2.78)
   
Shares outstanding (basic)   [+]25.817.211.96.132.227.427.326.8
Shares outstanding (diluted)   [+]25.817.211.96.132.227.427.326.8
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy